The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
25-hydroxyvitamin D levels and survival in patients with advanced pancreatic cancer (APC): Findings from CALGB 80303.
Katherine Van Loon
No relevant relationships to disclose
Kouros Owzar
No relevant relationships to disclose
Chen Jiang
No relevant relationships to disclose
Hedy Lee Kindler
Consultant or Advisory Role - Genentech/Roche
Research Funding - Genentech/Roche
Mary Frances Mulcahy
No relevant relationships to disclose
Donna Niedzwiecki
No relevant relationships to disclose
Eileen Mary O'Reilly
No relevant relationships to disclose
Charles S. Fuchs
No relevant relationships to disclose
Federico Innocenti
No relevant relationships to disclose
Alan Paul Venook
No relevant relationships to disclose